Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hamilton

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Molecular Psychiatry|April 11, 2023
Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulationIrene Perini, Leah M Mayo, Andrea J Capusan, et al.
Metabolites|May 26, 2023
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic OptionsBilal Bashir, Jan H Ho, Paul Downie, et al.
Infectious Diseases and Therapy|December 16, 2023
Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II StudiesChris Wynne, Abundio Balgos, Jingxin Li, et al.
Infectious Diseases and Therapy|June 14, 2024
Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II StudiesChris Wynne, Abundio Balgos, Jingxin Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2024
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National RegistryBilal Bashir, Paul Downie, Natalie Forrester, et al.
Atherosclerosis|March 6, 2024
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)Bilal Bashir, See Kwok, Anthony S Wierzbicki, et al.
Biological Psychology|May 25, 2010
Neural and behavioral responses to threatening emotion faces in children as a function of the short allele of the serotonin transporter geneMoriah E Thomason, Melissa L Henry, J Paul Hamilton, et al.
Translational Psychiatry|December 4, 2018
Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent <sup>11</sup>C-raclopride positron emission tomography and functional magnetic resonance imaging investigationJ Paul Hamilton, Matthew D Sacchet, Trine Hjørnevik, et al.
Genetics in Medicine Open|September 8, 2025
Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United KingdomBilal Bashir, Natalie Forrester, Paul Downie, et al.
Schizophrenia Bulletin|October 8, 2021
Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research CollaborationAkihiro Takamiya, Annemiek Dols, Louise Emsell, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Molecular Psychiatry|April 11, 2023
Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulationIrene Perini, Leah M Mayo, Andrea J Capusan, et al.
Metabolites|May 26, 2023
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic OptionsBilal Bashir, Jan H Ho, Paul Downie, et al.
Infectious Diseases and Therapy|December 16, 2023
Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II StudiesChris Wynne, Abundio Balgos, Jingxin Li, et al.
Infectious Diseases and Therapy|June 14, 2024
Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II StudiesChris Wynne, Abundio Balgos, Jingxin Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2024
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National RegistryBilal Bashir, Paul Downie, Natalie Forrester, et al.
Atherosclerosis|March 6, 2024
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)Bilal Bashir, See Kwok, Anthony S Wierzbicki, et al.
Biological Psychology|May 25, 2010
Neural and behavioral responses to threatening emotion faces in children as a function of the short allele of the serotonin transporter geneMoriah E Thomason, Melissa L Henry, J Paul Hamilton, et al.
Translational Psychiatry|December 4, 2018
Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent <sup>11</sup>C-raclopride positron emission tomography and functional magnetic resonance imaging investigationJ Paul Hamilton, Matthew D Sacchet, Trine Hjørnevik, et al.
Genetics in Medicine Open|September 8, 2025
Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United KingdomBilal Bashir, Natalie Forrester, Paul Downie, et al.
Schizophrenia Bulletin|October 8, 2021
Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research CollaborationAkihiro Takamiya, Annemiek Dols, Louise Emsell, et al.
Pageof 15